Skip to main content

By · Updated

Quick answer From $99/mo

Compounded semaglutide from $99/mo and tirzepatide from $150/mo on 12-month plans, same price at every dose. FDA warning letter for misleading claims in 2025.

Provider Review · Updated November 2026

Lovely Meds Review 2026: Flat Dose Pricing, FDA Warning Letter

Lovely Meds is a telehealth platform that sells compounded semaglutide and compounded tirzepatide. As of Nov 4, 2026, its weight loss page lists semaglutide at $99 to $175/month and tirzepatide at $150 to $235/month depending on plan length, with "all doses the same price." The FDA sent the company a warning letter in September 2025 over claims that its compounded drugs had the "same active ingredient" as Wegovy, Ozempic, Zepbound and Mounjaro. On Trustpilot it rates 3.8 from 692 reviews as of Nov 4, 2026.


Quick Facts

DetailLovely Meds (as of Nov 4, 2026)
Compounded semaglutide$175/mo (1 month), $145 (3 months), $120 (6 months), $99 (12 months)
Compounded tirzepatide$235/mo (1 month), $199 (3 months), $175 (6 months), $150 (12 months)
Dose pricingSame price at every dose
New customer promoFirst month $39 with code NEW60
FormatsInjection kits with B12, plus oral dissolving tablets
Brand-name GLP-1s listedZepbound, Mounjaro, Wegovy, Ozempic, Wegovy pill, Foundayo
States not servedKansas, Louisiana, Mississippi, New Mexico
InsuranceNot mentioned on the weight loss page
Address on FDA letterClarksville, MD
LeadershipNot named on the site
Trustpilot3.8 from 692 reviews
FDA warning letterIssued September 9, 2025

What Is Lovely Meds?

Lovely Meds is a telehealth platform that connects patients with clinicians who can prescribe compounded GLP-1s. Its weight loss page also lists brand-name drugs, plus other categories such as ED and longevity treatments.

The site claims “20,000+ people” and “20k+ patients treated across the US.” We could not verify that number.

The FDA warning letter was addressed to Lovely Meds, Inc. in Clarksville, Maryland. The website does not name a founder, CEO, or medical director.


Pricing

Lovely Meds used to hide its prices behind an intake form. That changed. The weight loss page now publishes full plan pricing.

Plan lengthSemaglutideTirzepatide
1 month$175/mo$235/mo
3 months$145/mo$199/mo
6 months$120/mo$175/mo
12 months$99/mo$150/mo

Both products say “All doses the same price, plans based on frequency.” That matters because GLP-1 doses go up over the first few months. A flat price means the cost should not climb as you titrate. The semaglutide product page describes an injection kit that “Includes B12.”

New customers get $60 off with code NEW60, which makes the first month $39, according to the weight loss page. The lowest monthly prices need a 12-month plan, so check whether that plan is paid up front and what the cancellation terms are before you commit.

For a wider price comparison, see our cheapest GLP-1 guide.

See Lovely Meds pricing and programs

Visit Lovely Meds →

How Lovely Meds Works

  1. Complete an online health form. The site advertises a free consultation.
  2. A licensed clinician reviews your information.
  3. If approved, a prescription is sent to a compounding pharmacy.
  4. Medication ships in discreet packaging. The site promises “fast shipping” but gives no time frame.
  5. Support. The weight loss page lists two different weekday support schedules (8 am to 2 pm and 8 am to 5 pm Eastern), so confirm hours before you rely on them.

Completing the intake does not guarantee a prescription. Follow the dosing schedule your prescriber sets.


FDA Warning Letter (September 2025)

On September 9, 2025, the FDA issued a warning letter to Lovely Meds, Inc. about claims on its website. The claims the FDA cited were:

  • “Same active ingredient as Wegovy and Ozempic”
  • “Same active ingredient as Zepbound & Mounjaro”

The FDA said the compounded semaglutide and tirzepatide products were misbranded under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. The company had 15 working days to respond.

The FDA sent letters with similar wording to other telehealth sellers on the same day, including Direct Meds. On Feb 6, 2026, the FDA restated that companies cannot claim compounded GLP-1s are generic versions of, or the same as, FDA-approved drugs.

A warning letter is about marketing claims. It is not a finding that the medication is unsafe. But compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality.


What I Like About Lovely Meds

Published, Flat Pricing

Every plan price is on the page, and the price does not change with dose. That makes it easy to estimate a full year of cost.

Both Semaglutide and Tirzepatide

You can switch molecules on the same platform. In the SURMOUNT-5 trial, brand-name tirzepatide produced a mean 20.2% weight loss versus 13.7% for brand-name semaglutide at 72 weeks. Those results came from FDA-approved products, not compounded versions.

Needle-Free Option

The weight loss page lists oral dissolving tablets for semaglutide and tirzepatide. Sublingual and oral compounded forms have far less published evidence than the approved injections.


What Could Be Better

FDA Warning Letter

The September 2025 letter is a regulatory mark against the company, even though other telehealth sellers got similar letters.

No Named Leadership

The site names no founder, CEO, or medical director. That is a transparency gap compared with providers that list their clinical leadership.

Mixed Trustpilot Reviews

A 3.8 score from 692 reviews on Trustpilot as of Nov 4, 2026 points to a mixed experience. Read the recent 1-star reviews before you buy.

Not Available Everywhere

The semaglutide page says it does not operate in Kansas, Louisiana, Mississippi, or New Mexico.


Safety Notes

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumors. Do not use them if you or a family member has had medullary thyroid carcinoma or MEN 2. The labels also warn about pancreatitis, gallbladder disease, kidney injury from dehydration, and use in pregnancy. See the Wegovy label and Zepbound label.


Who Lovely Meds Is Best For

Lovely Meds fits if you want compounded semaglutide or tirzepatide at a flat price across doses, and you accept the FDA warning letter and the lack of named leadership. It suits someone who:

  • Wants to know a full year of cost up front
  • Plans to move up in dose and does not want the price to rise
  • Is open to a 12-month plan to get the lowest price
  • Does not live in Kansas, Louisiana, Mississippi, or New Mexico

It is not the best fit if you want FDA-approved brand-name drugs with insurance help, a provider with named clinical leadership, or if the warning letter is a dealbreaker. Ro, for example, lists a $149/month membership plus brand-name medication on its weight loss page as of Nov 4, 2026.


The Bottom Line

Lovely Meds has fixed its biggest earlier problem. Prices are now published and flat across doses, from $99/month for semaglutide on a 12-month plan. The FDA warning letter, unnamed leadership, and a mixed Trustpilot score are the reasons for caution.

Compare all options in our provider directory or see the best GLP-1 programs for 2026.


FAQ

Is Lovely Meds legitimate?

Lovely Meds, Inc. is a real company that received an FDA warning letter in September 2025, addressed to Clarksville, Maryland. It rates 3.8 on Trustpilot from 692 reviews as of Nov 4, 2026. It does not name its leadership.

How much does Lovely Meds cost?

As of Nov 4, 2026, compounded semaglutide is $175/month on a 1-month plan down to $99/month on a 12-month plan. Compounded tirzepatide is $235/month down to $150/month. All doses cost the same.

Does Lovely Meds offer oral GLP-1 options?

Its weight loss page lists compounded oral dissolving tablets for semaglutide and tirzepatide, plus the brand-name Wegovy pill and Foundayo.

What was the FDA warning letter about?

The FDA cited claims that its compounded products had the “same active ingredient” as Wegovy, Ozempic, Zepbound, and Mounjaro, and said the products were misbranded.

What states does Lovely Meds serve?

Its semaglutide page says it does not operate in Kansas, Louisiana, Mississippi, or New Mexico, and that availability varies by state.

Who runs Lovely Meds?

No founder, CEO, or medical director is named on the website. The FDA letter was addressed to Clarksville, MD.


Guides:

Provider Reviews: SHED Review · Hims Review · Ro Review · Henry Meds Review · Fitish Review

Compare: All Providers · Best GLP-1 Programs 2026

What we checked

This AI-assisted public-source desk check reviewed the Lovely Meds weight loss and semaglutide pages, its Trustpilot profile, the FDA warning letters to Lovely Meds and Direct Meds, an FDA statement on compounded GLP-1s, the SURMOUNT-5 trial abstract, the Wegovy and Zepbound prescribing information, and Ro’s pricing page on November 4, 2026. We did not complete signup, pay for treatment, test delivery or support, or independently verify clinician and pharmacy credentials. Prices and policies change, so confirm them with the provider or your prescriber before you act.

Compare GLP-1 Providers →